Pricing

Free-pricing policy for non-prescription medicines is a determining factor for the effective function of a competitive market where manufacturers are incentivised to innovate and offer best value at affordable price to individuals. 

Pricing

This statement is supported by number of empirical evidence including policy recommendation by the European Commission. The European Commission Working group on Pricing and Reimbursement (2008), after a three-year consultation process, reached the conclusion that price competition can steer price evolution sufficiently well for non-reimbursable medicines, as non-prescription medicines. It thus recommended the EU member states should abstain from controlling the prices of these medicines.